Clinical Trials Directory

Trials / Recruiting

RecruitingNCT03005132

Integrative Analysis of Human Glioblastoma Multiforme

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,000 (estimated)
Sponsor
Shanghai 10th People's Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Integrative analysis of GBM

Detailed description

The investigators will analyzed proteomes of paired normal brain tissues and GBM, sequenced transcriptomes, perform whole exome sequencing, and single nucleotide polymorphism (SNP) array profiling for triplets, each comprising normal brain tissue, primary GBM carcinoma, and its synchronous matched metastasis, as well as analyzed genomics of GBM characterized previously by The Cancer Genome Atlas (TCGA) to conduct integrated proteogenomic analyses.

Conditions

Interventions

TypeNameDescription
OTHERNormal brain tissueThe investigators will extract total protein, DNA and RNA from the samples.

Timeline

Start date
2016-01-01
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2016-12-29
Last updated
2016-12-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03005132. Inclusion in this directory is not an endorsement.

Integrative Analysis of Human Glioblastoma Multiforme (NCT03005132) · Clinical Trials Directory